QPP: Protease that Prevents Apoptosis in Quiescent Cells
QPP: Protease that Prevents Apoptosis in Quiescent Cells
批准号:
7003713
负责人:
Brigitte T. Huber
金额:
$30.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2007-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): QPP (Quiescent cell Proline di-Peptidase), also termed DPP2/7, is a vesicular protease that cleaves dipeptides from the N-terminus of proteins, thereby impacting their half-life and/or receptor specificity. While the full functional profile of this enzyme is far from understood, in vitro experiments demonstrate that QPP is a major regulator of the G0 quiescence program in primary lymphocytes and neuronal cells. The primary objective of this renewal application is to analyze the mechanism of QPP-mediated survival in resting lymphocytes. Aim I: The most direct approach to define the functional role of QPP is to generate a mutant mouse deficient in QPP. Since previous attempts to derive conventional QP-/- mice were curbed by embryonic lethality, we propose a novel alternative to generate the mutant mouse, utilizing the Cre/IoxP recombinase system that allows conditional and inducible genome alterations. Aim II: Inhibition of QPP advances quiescent lymphocytes into cell cycle, leading to upregulation of c- Myc and p53 and finally apoptosis induction. Thus, it is postulated that QPP enzyme activity is required for maintaining the Go program. To test this hypothesis, the control of expression and mechanism of action of QPP will be delineated. Special emphasis will be given to LKLF and STAT5, two transcription factors that are implicated in positive and negative regulation of QPP expression, respectively. Furthermore, the role of c-Myc and p53 in the apoptosis pathway will be analyzed. Aim III: To fully understand the G0 survival program in eukaryotic cells, it is essential to define the physiological substrate(s) of QPP. Since this is the most ambitious project, various approaches will be used to reach this goal, including the screen of combinatorial dipeptide substrate libraries, the structural comparison of human and murine QPP with that of DPP4, and the isolation of a physiological substrate(s) by affinity matrix chromatography. Collectively, these studies will augment our limited understanding of the constitutive Go survival program in eukaryotic cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS
-
批准号:8365792
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2011
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS
-
批准号:8171443
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2010
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
-
批准号:7723039
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2008
-
负责人:Brigitte T. Huber
-
依托单位:
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS
-
批准号:7723069
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2008
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:7366904
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:7924814
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS
-
批准号:7602063
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:8132466
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
-
批准号:7602033
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:7674657
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:7500307
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETR
-
批准号:7369260
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2006
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
-
批准号:7369315
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2006
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETR
-
批准号:7182215
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2005
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
-
批准号:7182270
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2005
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETRY
-
批准号:6978518
-
项目类别:
-
资助金额:$2.49万
-
财政年份:2004
-
负责人:Brigitte T. Huber
-
依托单位:
Multidisciplinary Biodefense Training Program
-
批准号:7274181
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2003
-
负责人:Brigitte T. Huber
-
依托单位:
Multidisciplinary Biodefense Training Program
-
批准号:6892069
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2003
-
负责人:Brigitte T. Huber
-
依托单位:
Multidisciplinary Biodefense Training Program
-
批准号:7101005
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2003
-
负责人:Brigitte T. Huber
-
依托单位:
Multidisciplinary Biodefense Training Program
-
批准号:6782723
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2003
-
负责人:Brigitte T. Huber
-
依托单位:
国内基金
海外基金
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
-
批准号:31270835
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张云
-
依托单位:
三角帆蚌丝氨酸蛋白酶(serine protease)基因的克隆、表达调控与功能研究
-
批准号:31040083
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:肖调义
-
依托单位: